Ledderhose Disease - Long Term Effects of Radiotherapy Treatment. LedRad LTE - Study

NCT04229147 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2024-02-28

No results posted yet for this study

Summary

The aim of the LedRad LTE study is to determine the current complaints, late side effects and satisfaction of patients who were treated with radiotherapy for Ledderhose disease at least two years ago.

Conditions

  • Ledderhose Disease

Interventions

RADIATION

Radiotherapy

Patients who received a total dose of 30 Gy

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-13
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04229147 on ClinicalTrials.gov